ArticleThe Journal of pharmacology and experimental therapeutics2019

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models.

Joseph Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.